PDIA3
Protein disulfide-isomerase A3
Also known as: ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PDIA3_HUMAN, PI-PLC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30101
- Gene
- PDIA3
- Ensembl
- ENSG00000167004
- Chromosome
- 15
- Canonical length
- 505 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a protein of the endoplasmic reticulum that interacts with lectin chaperones calreticulin and calnexin to modulate folding of newly synthesized glycoproteins. The protein was once thought to be a phospholipase; however, it has been demonstrated that the protein actually has protein disulfide isomerase activity. It is thought that complexes of lectins and this protein mediate protein folding by promoting formation of disulfide bonds in their glycoprotein substrates. This protein also functions as a molecular chaperone that prevents the formation of protein aggregates. [provided by RefSeq, Dec 2016]
Canonical amino-acid sequenceUniProt
505 residues, UniProt reviewed canonical sequence.
>P30101|PDIA3
1 MRLRRLALFP GVALLLAAAR LAAASDVLEL TDDNFESRIS DTGSAGLMLV EFFAPWCGHC
61 KRLAPEYEAA ATRLKGIVPL AKVDCTANTN TCNKYGVSGY PTLKIFRDGE EAGAYDGPRT
121 ADGIVSHLKK QAGPASVPLR TEEEFKKFIS DKDASIVGFF DDSFSEAHSE FLKAASNLRD
181 NYRFAHTNVE SLVNEYDDNG EGIILFRPSH LTNKFEDKTV AYTEQKMTSG KIKKFIQENI
241 FGICPHMTED NKDLIQGKDL LIAYYDVDYE KNAKGSNYWR NRVMMVAKKF LDAGHKLNFA
301 VASRKTFSHE LSDFGLESTA GEIPVVAIRT AKGEKFVMQE EFSRDGKALE RFLQDYFDGN
361 LKRYLKSEPI PESNDGPVKV VVAENFDEIV NNENKDVLIE FYAPWCGHCK NLEPKYKELG
421 EKLSKDPNIV IAKMDATAND VPSPYEVRGF PTIYFSPANK KLNPKKYEGG RELSDFISYL
481 QREATNPPVI QEEKPKKKKK AQEDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDIA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 292 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 292 nTPM
- epididymis: 124 nTPM
- placenta: 118 nTPM
- rectum: 117 nTPM
- liver: 113 nTPM
- smooth muscle: 106 nTPM
Single-cell type
- syncytiotrophoblasts: 1,401 nCPM
- extravillous trophoblasts: 1,162 nCPM
- epididymal principal cells: 1,120 nCPM
- cytotrophoblasts: 783 nCPM
- migrating cytotrophoblasts: 701 nCPM
- decidual stromal cells: 691 nCPM
Immune cell
- total PBMC: 342 nTPM
- eosinophil: 182 nTPM
- plasmacytoid DC: 176 nTPM
- NK-cell: 173 nTPM
- gdT-cell: 168 nTPM
- MAIT T-cell: 152 nTPM
Brain region
- choroid plexus: 41 nTPM
- thalamus: 29 nTPM
- white matter: 27 nTPM
- hypothalamus: 25 nTPM
- medulla oblongata: 24 nTPM
- cerebral cortex: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDIA3.
Disease | ImmuneIEDB
Conditions an epitope on PDIA3 was assayed in.
- autoimmune hepatitis B cell
- type 1 diabetes mellitus T cell
ReferencesPubMed · IEDB
Publications for PDIA3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
6 publications
- Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.
2016 · Transl Res · RCR 0.8 · 25 citations - The expression of anti-protein disulfide isomerase A3 autoantibody is associated with the increased risk of miscarriage in euthyroid women with thyroid autoimmunity.
2022 · Int Immunopharmacol · RCR 0.6 · 5 citations - A Predictive Role of Autoantibodies Against the Epitope aa168-183 of ENO1 in the Occurrence of Miscarriage Related to Thyroid Autoimmunity.
2022 · Front Immunol · RCR 0.5 · 4 citations - The role of protein disulphide-isomerase A3 as autoantigen in the pathogenesis of autoimmune thyroiditis and related brain damage in adult mice.
2020 · Clin Immunol · RCR 0.5 · 11 citations - Unveiling the link: anti-protein disulfide isomerase A3 autoantibody expression and polycystic ovary syndrome risk in euthyroid autoimmune thyroiditis women.
2024 · J Ovarian Res · RCR 0.3 · 1 citations
Reference: B cellIEDB
1 publication
- LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
2010 · Drug Metab Pharmacokinet · RCR 0.5 · 20 citations
Reference: T cellIEDB
1 publication
- The antigen presentation landscape of cytokine-stressed human pancreatic islets.
2025 · Cell Rep · RCR 2.5 · 8 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cellular response to interleukin-7
- extrinsic apoptotic signaling pathway
- peptide antigen assembly with MHC class I protein complex
- platelet aggregation
- positive regulation of extrinsic apoptotic signaling pathway
- protein folding
- protein folding in endoplasmic reticulum
- response to endoplasmic reticulum stress
Molecular functions
- cysteine-type endopeptidase activity
- disulfide oxidoreductase activity
- identical protein binding
- lncRNA binding
- phospholipase C activity
- protein disulfide isomerase activity
- protein folding chaperone
- protein-disulfide reductase activity
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein disulfide-isomerase, thioredoxin-like domain
- Protein disulphide isomerase
- Thioredoxin domain
- Thioredoxin, conserved site
- Thioredoxin-like superfamily
- Thioredoxin
- Thioredoxin-like domain
- Protein disulfide-isomerase A3, first redox inactive TRX-like domain b
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDIA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDIA3 as an antibody target. Whether an autoantibody or antibody against PDIA3 could matter depends on whether native PDIA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDIA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDIA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...